Hou Shi-Fang, Jian Yin, Qiao Li-yan, Li Zun-Bao, F. Kai, Xu Xian-hao
{"title":"注意DMD在多发性硬化症治疗中的致畸作用","authors":"Hou Shi-Fang, Jian Yin, Qiao Li-yan, Li Zun-Bao, F. Kai, Xu Xian-hao","doi":"10.17352/2455-1414.000081","DOIUrl":null,"url":null,"abstract":"More than 2.3 million people are affected by Multiple Sclerosis (MS) worldwide. Since the 1990s, disease modifying drug (DMD) has been developing increasingly. With more and more clinical applications, more and more attention has been paid to the adverse effects of DMD in the treatment of MS. DMD selection for patients with MS during pregnancy is one of the most important topics for neuroimmunologists and obstetrics. This comment is mainly based on our published and forthcoming data.","PeriodicalId":15586,"journal":{"name":"Journal of Clinical Research","volume":"7 1","pages":"099-100"},"PeriodicalIF":0.0000,"publicationDate":"2020-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Draw attention to the teratogenic effect of DMD in MS treatment\",\"authors\":\"Hou Shi-Fang, Jian Yin, Qiao Li-yan, Li Zun-Bao, F. Kai, Xu Xian-hao\",\"doi\":\"10.17352/2455-1414.000081\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"More than 2.3 million people are affected by Multiple Sclerosis (MS) worldwide. Since the 1990s, disease modifying drug (DMD) has been developing increasingly. With more and more clinical applications, more and more attention has been paid to the adverse effects of DMD in the treatment of MS. DMD selection for patients with MS during pregnancy is one of the most important topics for neuroimmunologists and obstetrics. This comment is mainly based on our published and forthcoming data.\",\"PeriodicalId\":15586,\"journal\":{\"name\":\"Journal of Clinical Research\",\"volume\":\"7 1\",\"pages\":\"099-100\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.17352/2455-1414.000081\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17352/2455-1414.000081","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Draw attention to the teratogenic effect of DMD in MS treatment
More than 2.3 million people are affected by Multiple Sclerosis (MS) worldwide. Since the 1990s, disease modifying drug (DMD) has been developing increasingly. With more and more clinical applications, more and more attention has been paid to the adverse effects of DMD in the treatment of MS. DMD selection for patients with MS during pregnancy is one of the most important topics for neuroimmunologists and obstetrics. This comment is mainly based on our published and forthcoming data.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
